CAMEO+ eventHEALTH2026-04-24馃嚭馃嚫
CGBIO gets FDA 510(k) clearance for patient-specific titanium implant EASYMADE TI
source: U.S. Food and Drug Administration -> target: CGBIO
On 2026-04-24, the U.S. Food and Drug Administration granted 510(k) clearance to CGBIO for its patient-specific titanium implant EASYMADE TI. The device is intended for reconstruction of cranial and non-load-bearing craniofacial defects, according to the article.
0.15Significance2.0Magnitude0.2Systemic0.3Market1Articles
Location
Silver SpringMarylandNorth AmericaUnited StatesNorth America38.994, -77.009
Story Links